Answers are grounded in this paper and cite their sources.
Reliable, high-quality HER2-testing methods are essential for selection of patients with HER2-positive breast cancer for HER2-tageted treatment. Integration of our model into a locally used software or website may improve its viability for use in clinical practice.
No takes yet. Share an insight, caveat, or question.
Rüschoff et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: